tuberculosi
tb
one
top
caus
death
worldwid
sever
vitro
vivo
experiment
model
use
studi
tb
pathogenesi
induct
immun
respons
mycobacterium
tuberculosi
infect
precis
cut
lung
tissu
slice
pclt
experiment
model
usual
cell
type
organ
found
tissu
architectur
interact
amongst
differ
cell
maintain
pclt
good
physiolog
condit
monitor
mtt
assay
histolog
infect
either
virul
mycobacterium
tuberculosi
strain
tb
vaccin
strain
mycobacterium
bovi
bcg
histolog
analysi
show
bacilli
infect
lung
tissu
slice
observ
alveolar
septa
alveolar
light
space
near
type
ii
pneumocyt
insid
macrophag
mycobacteri
infect
pclt
induc
tnfa
product
consist
previou
tuberculosi
vitro
vivo
studi
first
report
use
pclt
system
studi
tuberculosi
infect
pclt
model
provid
use
tool
evalu
innat
immun
respons
aspect
earli
stage
mycobacteri
infect
mycobacterium
tuberculosi
primari
caus
human
tuberculosi
tb
infect
one
third
human
lead
caus
death
singl
infecti
agent
divers
approach
use
studi
tb
pathogenesi
discoveri
mechan
adher
infect
rout
secret
contactdepend
bacteri
factor
evas
immun
respons
signal
dissemin
tissu
possibl
use
vitro
vivo
model
studi
reveal
use
inform
aid
develop
product
strategi
prevent
treat
tb
vitro
well
vivo
experiment
system
advantag
limit
becom
complementari
dissect
pathogen
mechan
microorgan
host
immun
respons
altern
model
bridg
vivo
vitro
ex
vivo
model
use
origin
tissu
explant
precis
cut
lung
tissu
slice
pclt
system
typic
cell
type
organ
found
tissu
architectur
interact
differ
cell
maintain
metabol
transport
function
preserv
lung
tissu
slice
use
toxic
studi
biotransform
metabol
xenobiot
studi
infecti
agent
like
coronaviru
retroviru
influenza
parainfluenza
viral
strain
virus
bovin
respiratori
diseas
complex
respiratori
syncyti
viru
rsv
one
bacteria
chlamydophila
pneumonia
report
show
lung
tissu
slice
use
model
differ
aspect
infect
process
variou
pathogen
current
studi
optim
pclt
use
altern
model
studi
mycobacteri
infect
lung
tissu
bacteri
strain
growth
condit
tuberculosi
strain
bovi
bcg
cultur
middlebrook
broth
supplement
oleic
acidalbumin
dextrosecatalas
oadc
grown
midlogarithm
phase
store
c
need
bacteri
titer
batch
frozen
stock
determin
triplic
colonyform
unit
cfu
count
middlebrook
agar
infect
experi
aliquot
bacteri
stock
thaw
c
mix
vigor
vortex
dilut
tissuecultur
medium
provid
inocula
achiev
multipl
infect
moi
indic
moi
confirm
prepar
cfu
count
middlebrook
agar
experi
pclt
prepar
week
old
male
balbc
mice
mu
musculu
harlan
mexico
mice
euthan
cervic
disloc
follow
institut
intern
guidelin
humanitarian
care
anim
use
experiment
work
pleural
caviti
expos
asept
condit
trachea
cannul
infiltr
lung
lowgel
temperatur
agaros
rpmi
medium
c
tissu
allow
cool
ice
obtain
appropriatelyfirm
consist
cut
slice
lung
excis
immers
steril
krebshenseleit
kb
buffer
ph
c
five
millimet
diamet
core
lung
tissu
obtain
core
cut
brendel
vitron
tissu
slicer
vitron
tucson
az
usa
oxygen
kb
buffer
c
co
mm
thick
tissu
slice
pclt
transfer
micropl
one
per
well
ml
medium
supplement
bovin
fetal
serum
mm
glucos
pclt
incub
c
co
orbit
shaker
rpm
h
medium
chang
everi
min
remov
agaros
viabil
pclt
determin
tetrazolium
dye
mtt
bromid
assay
well
plate
od
valu
read
micropl
reader
synergi
ht
biotek
winooski
vt
usa
viabil
pclt
h
data
shown
immedi
last
wash
remov
agaros
pclt
infect
bacteri
inoculum
ml
appli
top
slice
infect
lung
slice
incub
stationari
h
facilit
adher
infect
ml
complet
medium
ad
well
micropl
incub
c
orbit
shaker
rpm
differ
infect
period
cfu
determin
plate
triplic
middlebrook
agar
time
point
indic
infect
time
pclt
fix
buffer
formalin
pb
c
h
inactiv
mycobacteria
differ
micropl
use
time
point
avoid
formaldehyd
vapor
affect
slice
cultur
infect
control
slice
embed
paraffin
use
autom
tissu
processor
citadel
shandon
pennsylvania
usa
section
mm
thick
obtain
embed
tissu
use
microtom
vitron
inc
tucson
az
section
stain
hematoxylin
eosin
h
e
ziehlneelsen
zn
dye
visual
convent
light
microscop
time
point
uninfect
infect
pclt
transfer
rnalat
solut
kept
c
h
store
c
rna
extract
sampl
time
use
rneasi
protect
mini
kit
qiagen
follow
manufactur
instruct
quantiti
puriti
rna
determin
use
nanodrop
spectrophotomet
thermo
scientif
massachusett
usa
integr
rna
visual
agaros
gel
denatur
condit
revers
transcript
perform
use
impromii
revers
transcript
system
promega
madison
wisconsin
usa
random
hexam
follow
manufactur
instruct
gener
cdna
store
c
use
quantit
pcr
assay
tnfa
carri
use
gene
express
assay
label
dyemgb
probe
appli
biosystem
endogen
gene
express
control
murin
gapdh
gene
label
vic
dyemgb
probe
use
reaction
mix
contain
ml
taqman
univers
pcr
master
mix
ml
taqman
gene
express
assay
mix
ml
cdna
ngml
ml
nucleasefre
water
final
volum
ml
pcr
run
real
time
pcr
system
appli
biosystem
use
follow
paramet
c
min
c
min
c
c
min
step
repeat
time
cycl
threshold
c
data
export
excel
calcul
express
level
compar
infect
vs
infect
tissu
lung
slice
time
point
ddc
method
use
follow
equat
anova
analysi
use
dunnett
method
p
comparison
mean
perform
determin
signific
valu
differ
time
point
histopatholog
analysi
balbc
mous
pclt
h
e
stain
show
uninfect
lung
tissu
slice
maintain
normal
tissu
architectur
evid
tissu
damag
day
cultur
fig
infect
pclt
h
infect
increas
lymphocyt
area
bacilli
locat
fig
mycobacteria
infect
pclt
show
mild
inflammatori
respons
character
presenc
lymphocyt
macrophag
multinucl
cell
fig
show
pclt
section
infect
tuberculosi
bovi
bcg
differ
time
point
h
bovi
bcg
bacilli
mainli
locat
free
bacilli
alveolar
space
sometim
near
type
ii
pneumocyt
tuberculosi
bacilli
locat
nearer
alveolar
septa
near
contact
type
ii
pneumocyt
mycobacteriainfect
pclt
show
bacilli
alveolar
space
tendenc
group
alveolar
septum
near
contact
epitheli
cell
bacteria
seen
within
pneumocyt
meanwhil
intracellular
bacteria
observ
insid
macrophag
fig
presenc
multinucl
giant
cell
inflammatori
cell
aggreg
characterist
granulomat
diseas
like
tuberculosi
also
frequent
seen
fig
tabl
show
cfu
tuberculosi
bovi
bcg
plct
differ
time
point
static
differ
number
cfu
per
slice
comparison
tnfa
induct
mycobacteria
infect
ddct
method
indic
tnfa
express
higher
lung
tissu
slice
infect
bovi
bcg
infect
lung
slice
infect
tuberculosi
peak
express
h
tuberculosi
produc
increas
fold
bovi
bcg
increas
fold
fig
result
dunnett
analysi
tnfa
gene
express
statist
signific
bovi
bcg
h
tuberculosi
h
compar
control
valu
fig
despit
recent
tuberculosi
studi
remain
mani
unknown
mechan
associ
tuberculosi
pathogenesi
due
complex
interact
mycobacteria
host
cell
sever
vivo
vitro
model
use
obtain
inform
differ
aspect
tuberculosi
diseas
initi
progress
type
model
advantag
weak
end
becom
complementari
sourc
valuabl
data
tuberculosi
virul
factor
well
host
immun
respons
pathogen
present
altern
complementari
ex
vivo
model
use
murin
precis
cut
lung
tissu
slice
studi
tuberculosi
infect
system
usual
cell
type
lung
present
tissu
architectur
maintain
interact
differ
cell
also
import
metabol
transport
function
preserv
addit
present
virtual
imposs
stop
use
anim
research
support
moral
ethic
issu
handl
experiment
anim
model
reduc
number
anim
use
experi
main
target
organ
tuberculosi
infect
lung
therefor
respiratori
tissu
obviou
first
choic
evalu
pclt
studi
tuberculosi
interact
lung
cell
harford
hamlin
prepar
murin
tissu
slice
hand
report
lung
slice
infect
model
influenza
viru
confirm
good
physiolog
condit
tissu
presenc
activ
ciliari
movement
first
report
precis
cut
lung
slice
studi
publish
ebsen
et
al
lung
slice
infect
chlamydophila
pneumonia
respiratori
syncyti
viru
use
morpholog
analys
author
demonstr
bacteri
viral
infect
success
perform
system
pclt
studi
model
show
reproduc
pclt
good
physiolog
condit
time
assay
recent
pclt
sheep
infect
jaagsiekt
sheep
retroviru
caus
agent
ovin
pulmonari
adenocarcinoma
viru
abl
infect
cell
produc
new
infecti
virion
induc
cell
prolifer
also
infect
lung
slice
cell
express
marker
type
ii
pneumocyt
phosphoryl
akt
resembl
phenotyp
natur
experimentallyderiv
opa
sheep
critic
factor
pclt
model
tissu
maintain
good
physiolog
condit
perform
experi
previou
work
lab
show
murin
pclt
viabl
h
obtain
monitor
mtt
assay
histolog
studi
experi
studi
done
first
h
infect
assur
pclt
suitabl
work
umachandran
colleagu
show
condit
rat
pclt
metabol
viabl
h
short
time
compar
murin
pclt
howev
differ
may
due
tissu
obtain
incub
moreov
rat
slice
thick
mean
nm
may
limit
ga
exchang
adequ
nutrient
flow
tissu
compar
mm
thick
slice
one
main
goal
work
optim
obtain
cultur
establish
reproduc
tuberculosi
infect
previous
arriaga
et
al
detect
presenc
mycobacteri
dna
pcr
situ
macrophag
fibroblast
mice
pclt
migrat
immun
cell
signal
pclt
remain
immunolog
activ
henjakov
et
al
report
immunoact
substanc
lipopolysaccharid
lp
macrophageactiv
interferong
ifng
dexamethason
induc
characterist
respons
substanc
pclt
fact
support
model
suitabl
test
immun
respons
pathogen
studi
phenotyp
immun
cell
pclt
determin
kind
cell
interact
directli
mycobacterium
one
advantag
system
possibl
add
exogen
specif
immun
cell
type
pclt
analyz
role
cell
linag
challeng
microb
therefor
analyz
abil
pclt
respond
immunolog
test
tnfa
induct
pclt
infect
mycobacteria
bovi
bcg
induc
higher
amount
tnfa
tuberculosi
measur
qrtpcr
peak
express
h
infect
increas
fold
tuberculosi
bovi
bcg
respect
differ
express
due
differenti
growth
strain
differ
number
cfu
per
slice
statist
signific
shown
tabl
due
differenti
tnfa
induct
infect
strain
result
agre
report
wong
et
al
found
virul
strain
produc
lower
induct
tnfa
nonvirul
strain
find
suggest
virul
strain
may
inhibit
cellular
mechan
evad
innat
immun
respons
exampl
suppress
product
neg
regul
apoptosi
host
macrophag
would
allow
mycobacteria
surviv
insid
cell
protect
immun
respons
help
tissu
dissemin
report
ex
vivo
human
lung
tissu
infect
tuberculosi
avium
abscessu
ganbat
et
al
found
macrophag
neutrophil
monocyt
pneumocytesii
infect
mycobacteria
nuclear
alter
result
cell
death
depend
mycobacteri
speci
use
system
provid
similar
origin
lung
microenviron
nativ
cell
popul
orient
structur
integr
comparison
model
provid
homogen
tissu
size
favor
ga
exchang
nutrient
avail
allow
viabil
tissu
h
also
mycobacteri
inoculum
use
experi
lower
distribut
bacteria
easier
due
size
pclt
morpholog
chang
induct
tnfa
pclt
experiment
infect
mycobacteria
suggest
system
altern
model
studi
differ
aspect
tuberculosi
pathogenesi
control
condit
closest
way
occur
vivo
also
number
anim
use
approach
lower
typic
vivo
model
possibl
use
pclt
studi
immun
respons
virul
factor
action
even
test
therapeut
agent
facet
explor
futur
research
